Drug approvals

|

16

FDA Approves Fiasp® For Use In Insulin Pumps for Adults with T1 and T2 Diabetes

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) 100 u/mL to …

FDA Approves First Oral Formulation of Semaglutide For Adults with T2D

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2 …

Xeris Pharma Gets FDA Approval for GVOKE,™ First Ready-to-use Stable Liquid Glucagon

Xeris Pharmaceuticals, Inc. announced today that it has received regulatory approval from the U.S. Food and Drug Administration (FDA) for …

|

Diabetes Drug, Farxiga Shows Promise in Patients With Heart Failure

AstraZeneca announced this week positive results from a landmark trial which showed that its diabetes drug, Farxiga reduced cardiovascular instances, …

| | |

Glenmark to Sell Combination Therapy for Adults With Type 2 Diabetes in India

Glenmark Pharmaceuticals Ltd. announced it has received regulatory approval to market a combination of a novel drug, Remogliflozinc, and Metformin …

New Drug for Diabetes Related Vision Loss Approved in Australia

Patients in Australia with diabetes-induced eye disease now have a new treatment option. The Australian Therapeutic Goods Administration (TGS) has …

|

First and Only Nasally Administered Glucagon Approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment …

|

Astra Zeneca’s Drug Does Not Get FDA Approval for Type 1 Diabetes

AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a …

|

Novo Nordisk Seeks U.S. FDA Approval for Oral Type 2 Diabetes Medication

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

|

Eli Lilly and Company Will Introduce Generic Insulin at Half Price of Humalog

Eli Lilly and Company today announced it will introduce a lower-priced version of Humalog®(insulin lispro injection 100 units/mL) in the U.S. The …